This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Multiple Endocrine Neoplasia Type 2b: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Multiple Endocrine Neoplasia Type 2b shares some biological mechanisms with adrenal-gland-neoplasms, carcinoma, endocrine-gland-neoplasms, ganglioneuroma, hirschsprung-disease, hyperplasia, malignant-neoplasm-of-thyroid, malignant-neoplasms, medullary-carcinoma-of-thyroid, multiple-endocrine-neoplasia, multiple-endocrine-neoplasia-type-1, multiple-endocrine-neoplasia-type-2a, neoplasm-metastasis, neoplasms, neuroma, pheochromocytoma, thyroid-carcinoma-familial-medullary, thyroid-neoplasm.
Among the many pathways, these few ones have gauged particular interests from scientists studying Multiple Endocrine Neoplasia Type 2b, and have been seen in publications frequently: Catecholamine Secretion, Cell Adhesion, Cell Cycle, Cell Death, Cell Growth, Cell Migration, Cell Proliferation, Excretion, Immune Response, Innervation, Kidney Development, Localization, Oncogenesis, Pathogenesis, Pigmentation, Regeneration, Secretion, Spermatogenesis, Tissue Development
Quite a number of genes have been found to play important roles in Multiple Endocrine Neoplasia Type 2b, such as AKT1, CALCA, CCDC6, CEACAM5, CEACAM7, EDNRB, ELL, F9, GDNF, MEN1, MT1A, NTRK1, PSG2, PTCH1, RET, SHC1, SS18L1, TAS2R38. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.